Refine
Year of publication
Has Fulltext
- yes (42)
Is part of the Bibliography
- no (42)
Keywords
- Protestantismus (3)
- Vormärz (3)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Kirchengeschichte (2)
- Kirchenkritik (2)
- Rezension (2)
- transient elastography (2)
- 19. Jahrhundert (1)
- 3D orientation pattern of ciliary bundles (1)
- ALK-rearranged NSCLC (1)
- APRI (1)
- Acute kidney injury (1)
- Acute myeloid leukemia (1)
- All-trans retinoic acid (1)
- Anaplastic astrocytoma (1)
- Astrocytoma grades (1)
- BCOR (1)
- BCORL1 (1)
- Bleeding (1)
- Blood loss (1)
- Bochumer Forum zur Geschichte des Sozialen Protestantismus (3 : 2000 : Bochum) (1)
- Chemotherapy (1)
- Cleanliness level (1)
- Climate sciences (1)
- Clinical Trials and Observations (1)
- Clinical presentation (1)
- Colloids (1)
- Colon capsule endoscopy (1)
- Complementation rate (1)
- Deutsch (1)
- Deutschland (1)
- Diffuse astrocytoma (1)
- Evidence-based guidelines (1)
- FIB-4 (1)
- Forschungsbericht (1)
- Freireligiöse (1)
- Genossenschaft (1)
- Germanistik (1)
- Geschichte (1)
- Geschichte 1680-1820 (1)
- Glioblastoma (1)
- HBV (1)
- HES (1)
- Hearing enhancement (1)
- Heavy Ion Experiments (1)
- High-throughput screening (1)
- Huber, Victor Aimé (1)
- Hydroxyethyl starch (1)
- Hyperammonemic encephalopathy (1)
- Hypertension (1)
- INR (1)
- IgG4-related disease (1)
- Incomplete colonoscopy (1)
- Indeterminate biliary stricture (1)
- Interactive 3D models (1)
- International normalized ratio (1)
- Konferenz (1)
- Kongressbericht (1)
- Lexikon (1)
- Literatur (1)
- Low volume prep (1)
- Lung Cancer (1)
- Macula (1)
- Metternich, Klemens Wenzel Nepomuk Lothar von (1)
- Moderne (1)
- Modernisierung (1)
- Molecular modelling (1)
- Moviprep (1)
- Myeloid Neoplasia (1)
- Neonatal urea cycle disorders (1)
- Non-small cell lung cancer (1)
- Nucleophosmin-1 (1)
- Ocean sciences (1)
- Otolith (1)
- Palaeoceanography (1)
- Palaeoclimate (1)
- Phospho-soda (1)
- Pietismus (1)
- PillCamColon2 (1)
- Pilocytic astrocytoma (1)
- Point-of-care testing (1)
- Politik (1)
- Politikgeschichte (1)
- Polyps (1)
- Prognosis (1)
- Psoriasis vulgaris (1)
- RNASolution-state NMR (1)
- ROS1 (1)
- Religionskrititk (1)
- Schweiz (1)
- Soziale Frage (1)
- Sozialgeschichte (1)
- Sozialreformer (1)
- TP53 mutation status (1)
- Target validation (1)
- Theologie (1)
- Trauma (1)
- Treatment (1)
- Volume therapy (1)
- Wohnungswirtschaft (1)
- Württemberg (1)
- acoustic radiation force impulse (1)
- acoustic radiation force impulse imaging (1)
- acute myeloid leukemia (1)
- aging (1)
- ambulatory assessment (1)
- bile duct stenosis (1)
- biliary stricture (1)
- chronic hepatitis C (1)
- context (1)
- direct-acting antiviral (DAA) treatment (1)
- endoscopic retrograde cholangiopancreatography (1)
- endoscopy (1)
- eosinophilic cholangitis (1)
- experience sampling (1)
- fibrotest (1)
- liver cirrhosis (1)
- liver transplantation (1)
- loss-of-function (1)
- multidrug resistance (1)
- non-invasive fibrosis assessment (1)
- point shear wave elastography (1)
- portal hypertension (1)
- primary sclerosing cholangitis (1)
- real-life study (1)
- recurrent cholangitis (1)
- risk stratification (1)
- sequential ALK-inhibitor therapy (1)
- short-course antibiotic therapy (1)
- situation (1)
- survival (1)
Institute
Objectives: Stenosis of the biliary anastomosis predisposes liver graft recipients to bacterial cholangitis. Antibiotic therapy (AT) is performed according to individual clinical judgment, but duration of AT remains unclear.
Methods: All liver graft recipients with acute cholangitis according to the Tokyo criteria grade 1 and 2 after endoscopic retrograde cholangiography (ERC) were included. Outcome of patients treated with short AT (<7 days) was compared to long AT (>6 days). Recurrent cholangitis (RC) within 28 days was the primary end point.
Results: In total, 30 patients were included with a median of 313 (range 34–9849) days after liver transplantation until first proven cholangitis. Among 62 cases in total, 51/62 (82%) were graded as Tokyo-1 and 11/62 (18%) as Tokyo-2. Overall median duration of AT was 6 days (1–14) with 36 cases (58%) receiving short AT and 26 (42%) receiving long AT. RC was observed in 10 (16%) cases, without significant difference in occurrence of RC in short versus long AT cases. CRP and bilirubin were significantly higher in patients with long AT, while low serum albumin and low platelets were associated with risk of RC.
Conclusion: A shorter antibiotic course than 7 days shows good results in selected, ERC-treated patients for post-transplantation biliary strictures.
Background: Accurate assessment of hepatic fibrosis in patients with chronic HBeAg-negative Hepatitis B is of crucial importance not only to predict the long-term clinical course, but also to evaluate antiviral therapy indication. The aim of this study was to prospectively assess the utility of point shear wave elastography (pSWE) for longitudinal non-invasive fibrosis assessment in a large cohort of untreated patients with chronic HBeAg-negative hepatitis B virus (HBV) infection.
Methods: 407 consecutive patients with HBeAg-negative HBV infection who underwent pSWE, transient elastography (TE) as well as laboratory fibrosis markers, including fibrosis index based on four factors (FIB-4), aspartate to platelet ratio index (APRI) and FibroTest, on the same day were prospectively followed up for six years. Patients were classified into one of the three groups: inactive carriers (IC; HBV-DNA <2000 IU/mL and ALT <40 U/L); grey zone group 1 (GZ-1; HBV DNA <2000 IU/mL and ALT >40 U/L); grey zone group 2 (GZ-2; HBV-DNA >2000 IU/mL and ALT <40 U/L).
Results: pSWE results were significantly correlated with TE (r = 0.29, p < 0.001) and APRI (r = 0.17; p = 0.005). Median pSWE values did not differ between IC, GZ-1 and GZ-2 patients (p = 0.82, p = 0.17, p = 0.34). During six years of follow-up, median pSWE and TE values did not differ significantly over time (TE: p = 0.27; pSWE: p = 0.05).
Conclusion: Our data indicate that pSWE could be useful for non-invasive fibrosis assessment and follow-up in patients with HBeAg-negative chronic HBV infection.